FORUM MARKETS Inc received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)).
Exchange
nasdaq
Notice
deficiency notice
Deficiency
stockholders equity
Rules
5550(b)
Exact text from the filing
November 15, 2023, the Listing Qualifications department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) notified 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) that we did not comply with the minimum $2,500,000 stockholders’ equity requirement for continued listing set forth in Nasdaq Listing Rule 5550(b) (the “ Rule ”). Nasdaq provided the Company until January 2, 2024 to submit to Nasdaq a plan to regain compliance. We submitted the plan to regain compliance in a timely manner, and on January 11, 2024, Nasdaq advised the Company that it has determined to grant the
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.